These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Ohio | 34-0183970 | |
(State or other jurisdiction of incorporation or organization) | (IRS Employer Identification Number) | |
5995 Mayfair Road, PO Box 3077, North Canton, Ohio | 44720-8077 | |
(Address of principal executive offices) | (Zip Code) |
Large Accelerated Filer þ | Accelerated Filer o | Non-Accelerated Filer o | Smaller Reporting Company o | |||
(Do not check if a smaller reporting company)
|
3 | ||||||||
3 | ||||||||
3 | ||||||||
4 | ||||||||
5 | ||||||||
6 | ||||||||
20 | ||||||||
29 | ||||||||
29 | ||||||||
29 | ||||||||
29 | ||||||||
31 | ||||||||
31 | ||||||||
32 | ||||||||
32 | ||||||||
32 | ||||||||
32 | ||||||||
33 | ||||||||
34 | ||||||||
EX-31.1 | ||||||||
EX-31.2 | ||||||||
EX-32.1 | ||||||||
EX-32.2 | ||||||||
EX-101 INSTANCE DOCUMENT | ||||||||
EX-101 SCHEMA DOCUMENT | ||||||||
EX-101 CALCULATION LINKBASE DOCUMENT | ||||||||
EX-101 LABELS LINKBASE DOCUMENT | ||||||||
EX-101 PRESENTATION LINKBASE DOCUMENT |
2
March 31, | December 31, | |||||||
2011 | 2010 | |||||||
(Unaudited) | ||||||||
ASSETS
|
||||||||
Current assets
|
||||||||
Cash and cash equivalents
|
$ | 279,562 | $ | 328,658 | ||||
Short-term investments
|
272,644 | 273,123 | ||||||
Trade receivables, less allowances for doubtful accounts of $24,911
and $24,868, respectively
|
418,586 | 404,501 | ||||||
Inventories
|
474,125 | 444,575 | ||||||
Deferred income taxes
|
100,616 | 106,160 | ||||||
Prepaid expenses
|
32,248 | 32,111 | ||||||
Other current assets
|
143,450 | 124,908 | ||||||
|
||||||||
Total current assets
|
1,721,231 | 1,714,036 | ||||||
|
||||||||
|
||||||||
Securities and other investments
|
73,627 | 76,138 | ||||||
Property, plant and equipment, at cost
|
656,311 | 646,235 | ||||||
Less accumulated depreciation and amortization
|
453,772 | 442,773 | ||||||
|
||||||||
Property, plant and equipment, net
|
202,539 | 203,462 | ||||||
Deferred income taxes
|
54,718 | 49,961 | ||||||
Goodwill
|
272,394 | 269,398 | ||||||
Other assets
|
207,028 | 206,795 | ||||||
|
||||||||
Total assets
|
$ | 2,531,537 | $ | 2,519,790 | ||||
|
||||||||
|
||||||||
LIABILITIES AND EQUITY
|
||||||||
Current liabilities
|
||||||||
Notes payable
|
$ | 21,883 | $ | 15,038 | ||||
Accounts payable
|
187,682 | 214,288 | ||||||
Deferred revenue
|
231,982 | 205,173 | ||||||
Payroll and other benefits liabilities
|
54,911 | 78,515 | ||||||
Other current liabilities
|
291,619 | 296,751 | ||||||
|
||||||||
Total current liabilities
|
788,077 | 809,765 | ||||||
|
||||||||
|
||||||||
Long-term debt
|
615,010 | 550,368 | ||||||
Pensions and other benefits
|
79,955 | 100,152 | ||||||
Postretirement and other benefits
|
23,364 | 23,096 | ||||||
Deferred income taxes
|
32,068 | 31,126 | ||||||
Other long-term liabilities
|
15,779 | 15,469 | ||||||
|
||||||||
Commitments and contingencies
|
— | — | ||||||
|
||||||||
Equity
|
||||||||
Diebold, Incorporated shareholders’ equity
|
||||||||
Preferred shares, no par value, 1,000,000 authorized shares, none issued
|
— | — | ||||||
Common shares, $1.25 par value, 125,000,000 authorized shares, 76,794,248 and 76,365,124
issued shares, 65,528,307 and 65,717,103 outstanding shares, respectively
|
95,993 | 95,456 | ||||||
Additional capital
|
316,956 | 308,699 | ||||||
Retained earnings
|
903,147 | 919,296 | ||||||
Treasury shares, at cost (11,265,941 and 10,648,021 shares, respectively)
|
(457,373 | ) | (435,922 | ) | ||||
Accumulated other comprehensive income
|
88,307 | 73,626 | ||||||
|
||||||||
Total Diebold, Incorporated shareholders’ equity
|
947,030 | 961,155 | ||||||
Noncontrolling interests
|
30,254 | 28,659 | ||||||
|
||||||||
Total equity
|
977,284 | 989,814 | ||||||
|
||||||||
Total liabilities and equity
|
$ | 2,531,537 | $ | 2,519,790 | ||||
|
3
Three Months Ended | ||||||||
March 31, | ||||||||
2011 | 2010 | |||||||
Net sales
|
||||||||
Products
|
$ | 249,783 | $ | 257,745 | ||||
Services
|
364,374 | 361,254 | ||||||
|
||||||||
|
614,157 | 618,999 | ||||||
|
||||||||
Cost of sales
|
||||||||
Products
|
188,863 | 192,277 | ||||||
Services
|
275,890 | 268,712 | ||||||
|
||||||||
|
464,753 | 460,989 | ||||||
|
||||||||
Gross profit
|
149,404 | 158,010 | ||||||
Selling and administrative expense
|
121,111 | 98,977 | ||||||
Research, development and engineering expense
|
19,424 | 18,448 | ||||||
|
||||||||
|
140,535 | 117,425 | ||||||
|
||||||||
Operating profit
|
8,869 | 40,585 | ||||||
Other income (expense)
|
||||||||
Investment income
|
10,898 | 7,471 | ||||||
Interest expense
|
(8,673 | ) | (9,055 | ) | ||||
Foreign exchange loss, net
|
(1,046 | ) | (4,641 | ) | ||||
Miscellaneous, net
|
23 | 709 | ||||||
|
||||||||
Income from continuing operations before taxes
|
10,071 | 35,069 | ||||||
Taxes on income
|
5,925 | 9,877 | ||||||
|
||||||||
Income from continuing operations
|
4,146 | 25,192 | ||||||
Loss from discontinued operations, net of tax
|
(11 | ) | (970 | ) | ||||
|
||||||||
Net income
|
4,135 | 24,222 | ||||||
Net income attributable to noncontrolling interests
|
1,634 | 298 | ||||||
|
||||||||
Net income attributable to Diebold, Incorporated
|
$ | 2,501 | $ | 23,924 | ||||
|
||||||||
|
||||||||
Basic weighted-average shares outstanding
|
65,762 | 66,298 | ||||||
Diluted weighted-average shares outstanding
|
66,230 | 66,776 | ||||||
|
||||||||
Basic earnings per share
|
||||||||
Net income from continuing operations
|
$ | 0.04 | $ | 0.38 | ||||
Loss from discontinued operations
|
— | (0.02 | ) | |||||
|
||||||||
Net income attributable to Diebold, Incorporated
|
$ | 0.04 | $ | 0.36 | ||||
|
||||||||
|
||||||||
Diluted earnings per share
|
||||||||
Net income from continuing operations
|
$ | 0.04 | $ | 0.37 | ||||
Loss from discontinued operations
|
— | (0.01 | ) | |||||
|
||||||||
Net income attributable to Diebold, Incorporated
|
$ | 0.04 | $ | 0.36 | ||||
|
||||||||
|
||||||||
Amounts attributable to Diebold, Incorporated
|
||||||||
Income from continuing operations, net of tax
|
$ | 2,512 | $ | 24,894 | ||||
Loss from discontinued operations, net of tax
|
(11 | ) | (970 | ) | ||||
|
||||||||
Net income attributable to Diebold, Incorporated
|
$ | 2,501 | $ | 23,924 | ||||
|
4
Three Months Ended | ||||||||
March 31, | ||||||||
2011 | 2010 | |||||||
Cash flow from operating activities:
|
||||||||
Net income
|
$ | 4,135 | $ | 24,222 | ||||
Adjustments to reconcile net income to cash used in operating activities:
|
||||||||
Depreciation and amortization
|
19,246 | 19,587 | ||||||
Share-based compensation
|
3,435 | 3,226 | ||||||
Excess tax benefits from share-based compensation
|
(1,484 | ) | (131 | ) | ||||
Devaluation of Venezuelan balance sheet
|
— | 5,968 | ||||||
Equity in earnings of an investee
|
(425 | ) | (753 | ) | ||||
Cash (used in) provided by changes in certain assets and liabilities:
|
||||||||
Trade receivables
|
(8,072 | ) | (66,657 | ) | ||||
Inventories
|
(21,955 | ) | 3,573 | |||||
Prepaid expenses
|
158 | 7,277 | ||||||
Other current assets
|
(15,419 | ) | (30,849 | ) | ||||
Accounts payable
|
(29,404 | ) | (5,283 | ) | ||||
Deferred revenue
|
25,078 | 17,762 | ||||||
Certain other assets and liabilities
|
(65,444 | ) | (34,165 | ) | ||||
|
||||||||
Net cash used in operating activities
|
(90,151 | ) | (56,223 | ) | ||||
|
||||||||
Cash flow from investing activities:
|
||||||||
Proceeds from sale of discontinued operations
|
— | 1,202 | ||||||
Proceeds from maturities of investments
|
59,292 | 76,752 | ||||||
Proceeds from sale of investments
|
7,117 | — | ||||||
Payments for purchases of investments
|
(56,720 | ) | (63,719 | ) | ||||
Proceeds from sale of assets
|
175 | — | ||||||
Capital expenditures
|
(10,902 | ) | (11,103 | ) | ||||
Increase in certain other assets
|
(4,103 | ) | (5,864 | ) | ||||
Collections on purchased finance receivables
|
7,338 | — | ||||||
|
||||||||
Net cash provided by (used in) investing activities
|
2,197 | (2,732 | ) | |||||
|
||||||||
Cash flow from financing activities:
|
||||||||
Dividends paid
|
(18,650 | ) | (18,095 | ) | ||||
Debt borrowings
|
156,637 | 127,578 | ||||||
Debt repayments
|
(85,210 | ) | (93,370 | ) | ||||
Issuance of common shares
|
4,017 | 615 | ||||||
Repurchase of common shares
|
(21,451 | ) | (11,355 | ) | ||||
Other
|
615 | 131 | ||||||
|
||||||||
Net cash provided by financing activities
|
35,958 | 5,504 | ||||||
|
||||||||
|
||||||||
Effect of exchange rate changes on cash and cash equivalents
|
2,900 | (9,102 | ) | |||||
|
||||||||
Decrease in cash and cash equivalents
|
(49,096 | ) | (62,553 | ) | ||||
Cash and cash equivalents at the beginning of the period
|
328,658 | 328,426 | ||||||
|
||||||||
Cash and cash equivalents at the end of the period
|
$ | 279,562 | $ | 265,873 | ||||
|
5
2011 | 2010 | |||||||
Numerator:
|
||||||||
Income used in basic and diluted earnings per share:
|
||||||||
Income from continuing operations, net of tax
|
$ | 2,512 | $ | 24,894 | ||||
Loss from discontinued operations, net of tax
|
(11 | ) | (970 | ) | ||||
|
||||||||
Net income attributable to Diebold, Incorporated
|
$ | 2,501 | $ | 23,924 | ||||
|
||||||||
|
||||||||
Denominator (in thousands):
|
||||||||
Weighted-average number of common shares used in basic earnings per share
|
65,762 | 66,298 | ||||||
Effect of dilutive shares
|
468 | 478 | ||||||
|
||||||||
Weighted-average number of shares used in diluted earnings per share
|
66,230 | 66,776 | ||||||
|
||||||||
|
||||||||
Basic earnings per share:
|
||||||||
Income from continuing operations, net of tax
|
$ | 0.04 | $ | 0.38 | ||||
Loss from discontinued operations, net of tax
|
— | (0.02 | ) | |||||
|
||||||||
Net income attributable to Diebold, Incorporated
|
$ | 0.04 | $ | 0.36 | ||||
|
||||||||
|
||||||||
Diluted earnings per share:
|
||||||||
Income from continuing operations, net of tax
|
$ | 0.04 | $ | 0.37 | ||||
Loss from discontinued operations, net of tax
|
— | (0.01 | ) | |||||
|
||||||||
Net income attributable to Diebold, Incorporated
|
$ | 0.04 | $ | 0.36 | ||||
|
||||||||
|
||||||||
Anti-dilutive shares (in thousands):
|
||||||||
Anti-dilutive shares not used in calculating diluted weighted-average shares
|
2,023 | 2,393 |
6
2011 | 2010 | |||||||
Diebold, Incorporated shareholders’ equity
|
||||||||
Balance at beginning of the period
|
$ | 961,155 | $ | 1,046,379 | ||||
|
||||||||
Net income attributable to Diebold, Incorporated
|
2,501 | 23,924 | ||||||
Other comprehensive income (loss):
|
||||||||
Foreign currency translation
|
14,674 | (12,219 | ) | |||||
Interest rate hedges
|
(49 | ) | (187 | ) | ||||
Pensions and other postretirement benefits
|
729 | 1,363 | ||||||
Unrealized (loss) gain, net on available for sale securities
|
(673 | ) | 525 | |||||
|
||||||||
Comprehensive income attributable to Diebold, Incorporated
|
17,182 | 13,406 | ||||||
|
||||||||
Common shares
|
537 | 167 | ||||||
Additional capital
|
8,257 | 7,856 | ||||||
Treasury shares
|
(21,451 | ) | (11,355 | ) | ||||
Dividends declared
|
(18,650 | ) | (18,095 | ) | ||||
|
||||||||
Balance at end of the period
|
$ | 947,030 | $ | 1,038,358 | ||||
|
||||||||
|
||||||||
Noncontrolling interests
|
||||||||
Balance at beginning of the period
|
$ | 28,659 | $ | 25,647 | ||||
|
||||||||
Net income attributable to noncontrolling interests
|
1,634 | 298 | ||||||
Other comprehensive income (loss):
|
||||||||
Foreign currency translation
|
271 | (137 | ) | |||||
|
||||||||
Comprehensive income attributable to noncontrolling interests
|
1,905 | 161 | ||||||
Distributions to noncontrolling interest holders
|
(310 | ) | — | |||||
|
||||||||
Balance at end of the period
|
$ | 30,254 | $ | 25,808 | ||||
|
7
Weighted- | ||||||||||||||||
Weighted- | Average | |||||||||||||||
Average | Remaining | Aggregate | ||||||||||||||
Number of | Exercise | Contractual | Intrinsic | |||||||||||||
Shares | Price | Term | Value (1) | |||||||||||||
(in thousands) | (per share) | (in years) | ||||||||||||||
Outstanding at January 1, 2011
|
3,152 | $ | 36.67 | |||||||||||||
Expired or forfeited
|
(68 | ) | 28.76 | |||||||||||||
Exercised
|
(148 | ) | 27.06 | |||||||||||||
Granted
|
420 | 33.11 | ||||||||||||||
|
||||||||||||||||
Outstanding at March 31, 2011
|
3,356 | $ | 36.79 | 5 | $ | 10,444 | ||||||||||
|
||||||||||||||||
Options exercisable at March 31, 2011
|
2,279 | $ | 40.01 | 4 | 4,329 | |||||||||||
|
||||||||||||||||
Options vested and expected to vest (2) at March 31, 2011
|
3,330 | $ | 36.85 | 5 | 9,006 | |||||||||||
|
(1) | The aggregate intrinsic value (the difference between the closing price of the Company’s common shares on the last trading day of the first quarter of 2011 and the exercise price, multiplied by the number of “in-the-money” options) that would have been received by the option holders had all option holders exercised their options on March 31, 2011. The amount of aggregate intrinsic value will change based on the fair market value of the Company’s common shares. | |
(2) | The options expected to vest are the result of applying the pre-vesting forfeiture rate assumption to total outstanding non-vested options. |
Number of | Weighted-Average | |||||||
Shares | Grant-Date Fair Value | |||||||
(in thousands) | ||||||||
RSUs:
|
||||||||
Non-vested at January 1, 2011
|
594 | $ | 29.06 | |||||
Forfeited
|
(12 | ) | 26.79 | |||||
Vested
|
(87 | ) | 25.70 | |||||
Granted
|
269 | 32.93 | ||||||
|
||||||||
Non-vested at March 31, 2011
|
764 | $ | 30.84 | |||||
|
||||||||
|
||||||||
Performance Shares (1):
|
||||||||
Non-vested at January 1, 2011
|
742 | $ | 31.15 | |||||
Forfeited
|
(82 | ) | 30.23 | |||||
Vested
|
(176 | ) | 28.91 | |||||
Granted
|
236 | 39.85 | ||||||
|
||||||||
Non-vested at March 31, 2011
|
720 | $ | 34.65 | |||||
|
||||||||
|
||||||||
Director Deferred Shares:
|
||||||||
Non-vested at March 31, 2011
|
14 | $ | 33.28 | |||||
|
||||||||
Vested at March 31, 2011
|
76 | $ | 34.02 | |||||
|
||||||||
Outstanding at March 31, 2011
|
90 | $ | 33.91 | |||||
|
(1) | Non-vested performance shares are based on a maximum potential payout. Actual shares granted at the end of the performance period may be less than the maximum potential payout level depending on achievement of performance share objectives. |
8
Unrealized | ||||||||||||
Cost Basis | Gain (Loss) | Fair Value | ||||||||||
As of March 31, 2011
|
||||||||||||
Short-term investments:
|
||||||||||||
Certificates of deposit
|
$ | 227,705 | $ | — | $ | 227,705 | ||||||
U.S. dollar indexed bond funds
|
46,909 | (1,970 | ) | 44,939 | ||||||||
|
||||||||||||
|
$ | 274,614 | $ | (1,970 | ) | $ | 272,644 | |||||
|
||||||||||||
Long-term investments:
|
||||||||||||
Assets held in a rabbi trust
|
$ | 8,228 | $ | 463 | $ | 8,691 | ||||||
|
||||||||||||
|
||||||||||||
As of December 31, 2010
|
||||||||||||
Short-term investments:
|
||||||||||||
Certificates of deposit
|
$ | 221,706 | $ | — | $ | 221,706 | ||||||
U.S. dollar indexed bond funds
|
52,714 | (1,297 | ) | 51,417 | ||||||||
|
||||||||||||
|
$ | 274,420 | $ | (1,297 | ) | $ | 273,123 | |||||
|
||||||||||||
Long-term investments:
|
||||||||||||
Assets held in a rabbi trust
|
$ | 8,068 | $ | 95 | $ | 8,163 | ||||||
|
9
Finance | Notes | |||||||||||
Leases | Receivable | Total | ||||||||||
Allowance for credit losses
|
||||||||||||
Balance January 1, 2011
|
$ | 378 | $ | 470 | $ | 848 | ||||||
Provision for credit losses
|
17 | 1,217 | 1,234 | |||||||||
Recoveries
|
10 | — | 10 | |||||||||
Write-offs
|
(80 | ) | — | (80 | ) | |||||||
|
||||||||||||
Balance individually evaluated for impairment
|
$ | 325 | $ | 1,687 | $ | 2,012 | ||||||
Balance collectively evaluated for impairment
|
— | — | — | |||||||||
|
||||||||||||
Balance March 31, 2011
|
$ | 325 | $ | 1,687 | $ | 2,012 | ||||||
|
||||||||||||
|
||||||||||||
Recorded investment in financing receivables
|
||||||||||||
Balance individually evaluated for impairment
|
$ | 120,625 | $ | 24,287 | $ | 144,912 | ||||||
Balance collectively evaluated for impairment
|
— | — | — | |||||||||
|
||||||||||||
Balance March 31, 2011
|
$ | 120,625 | $ | 24,287 | $ | 144,912 | ||||||
|
31-60 days past due
|
$ | 206 | ||
61-90 days past due
|
— | |||
> 90 days past due
|
6,266 | |||
|
||||
Total past due
|
$ | 6,472 | ||
|
10
March 31, 2011 | December 31, 2010 | |||||||
Finished goods
|
$ | 193,700 | $ | 184,944 | ||||
Service parts
|
170,341 | 166,317 | ||||||
Raw materials and work in process
|
110,084 | 93,314 | ||||||
|
||||||||
Total inventories
|
$ | 474,125 | $ | 444,575 | ||||
|
March 31, 2011 | December 31, 2010 | |||||||
Notes payable — current:
|
||||||||
Uncommitted lines of credit
|
$ | 21,780 | $ | 15,038 | ||||
Other
|
103 | — | ||||||
|
||||||||
|
$ | 21,883 | $ | 15,038 | ||||
|
||||||||
|
||||||||
Long-term debt:
|
||||||||
Credit facility
|
$ | 300,000 | $ | 235,000 | ||||
Senior notes
|
300,000 | 300,000 | ||||||
Industrial development revenue bonds
|
11,900 | 11,900 | ||||||
Other
|
3,110 | 3,468 | ||||||
|
||||||||
|
$ | 615,010 | $ | 550,368 | ||||
|
11
2011 | 2010 | 2011 | 2010 | |||||||||||||
Pension Benefits | Other Benefits | |||||||||||||||
Components of net periodic benefit cost
|
||||||||||||||||
Service cost
|
$ | 2,713 | $ | 2,499 | $ | — | $ | — | ||||||||
Interest cost
|
7,872 | 7,681 | 233 | 248 | ||||||||||||
Expected return on plan assets
|
(10,183 | ) | (9,603 | ) | — | — | ||||||||||
Amortization of prior service cost
|
65 | 48 | (129 | ) | (129 | ) | ||||||||||
Recognized net actuarial loss
|
2,406 | 1,373 | 97 | 71 | ||||||||||||
|
||||||||||||||||
Net periodic pension benefit cost
|
$ | 2,873 | $ | 1,998 | $ | 201 | $ | 190 | ||||||||
|
12
2011 | 2010 | |||||||
Balance at January 1
|
$ | 78,313 | $ | 62,673 | ||||
Current period accruals (a)
|
18,411 | 10,924 | ||||||
Current period settlements
|
(19,252 | ) | (12,100 | ) | ||||
|
||||||||
Balance at March 31
|
$ | 77,472 | $ | 61,497 | ||||
|
(a) | includes the impact of foreign exchange rate fluctuations |
13
2011 | 2010 | Income Statement Location | ||||||||||
Foreign exchange contracts
|
$ | (1,849 | ) | $ | (1,486 | ) | Interest expense | |||||
Foreign exchange contracts
|
(6,217 | ) | 6,944 | Foreign exchange loss, net | ||||||||
|
||||||||||||
Total
|
$ | (8,066 | ) | $ | 5,458 | |||||||
|
2011 | 2010 | |||||||
Cost of sales — products
|
$ | 123 | $ | (214 | ) | |||
Cost of sales — services
|
6,074 | 314 | ||||||
Selling and administrative expense
|
5,604 | 1,157 | ||||||
Research, development and engineering expense
|
— | (141 | ) | |||||
|
||||||||
Total
|
$ | 11,801 | $ | 1,116 | ||||
|
2011 | 2010 | |||||||
DNA
|
||||||||
Severance
|
$ | (7 | ) | $ | 184 | |||
Other (1)
|
— | 131 | ||||||
DI
|
||||||||
Severance
|
11,605 | 1,365 | ||||||
Other (2)
|
203 | (564 | ) | |||||
|
||||||||
Total
|
$ | 11,801 | $ | 1,116 | ||||
|
(1) | Net other restructuring benefits in the DNA segment include an accrual adjustment related to the pension obligation. | |
(2) | Net other restructuring charges in the DI segment include legal and professional fees. |
14
Global | Global | |||||||||||
EMEA | Manufacturing | Workforce | ||||||||||
Reorganization | Realignment | Reductions | ||||||||||
Costs incurred to date:
|
||||||||||||
DNA
|
$ | — | $ | 11,579 | $ | 21,425 | ||||||
DI
|
11,580 | 25,178 | 20,571 | |||||||||
|
||||||||||||
Total costs incurred to date
|
$ | 11,580 | $ | 36,757 | $ | 41,996 | ||||||
|
Balance as of January 1, 2011
|
$ | 3,340 | ||
Liabilities incurred
|
11,801 | |||
Liabilities paid
|
(1,785 | ) | ||
|
||||
Balance as of March 31, 2011
|
$ | 13,356 | ||
|
15
March 31, 2011 | December 31, 2010 | |||||||||||||||||||||||||||||||
Fair Value Measurements Using | Fair Value Measurements Using | |||||||||||||||||||||||||||||||
Fair Value | Level 1 | Level 2 | Level 3 | Fair Value | Level 1 | Level 2 | Level 3 | |||||||||||||||||||||||||
Assets
|
||||||||||||||||||||||||||||||||
Short-term investments:
|
||||||||||||||||||||||||||||||||
Certificates of deposit
|
$ | 227,705 | $ | 227,705 | $ | — | $ | — | $ | 221,706 | $ | 221,706 | $ | — | $ | — | ||||||||||||||||
U.S. dollar indexed bond funds
|
44,939 | — | 44,939 | — | 51,417 | — | 51,417 | — | ||||||||||||||||||||||||
Assets held in a rabbi trust
|
8,691 | 8,691 | — | — | 8,163 | 8,163 | — | — | ||||||||||||||||||||||||
Foreign exchange forward contracts
|
1,180 | — | 1,180 | — | 925 | — | 925 | — | ||||||||||||||||||||||||
Contingent consideration on sale
of business
|
2,030 | — | — | 2,030 | 2,030 | — | — | 2,030 | ||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
Total
|
$ | 284,545 | $ | 236,396 | $ | 46,119 | $ | 2,030 | $ | 284,241 | $ | 229,869 | $ | 52,342 | $ | 2,030 | ||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
Liabilities
|
||||||||||||||||||||||||||||||||
Deferred compensation
|
$ | 8,691 | $ | 8,691 | $ | — | $ | — | $ | 8,163 | $ | 8,163 | $ | — | $ | — | ||||||||||||||||
Foreign exchange forward contracts
|
1,539 | — | 1,539 | — | 4,060 | — | 4,060 | — | ||||||||||||||||||||||||
Interest rate swaps
|
2,991 | — | 2,991 | — | 3,371 | — | 3,371 | — | ||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
Total
|
$ | 13,221 | $ | 8,691 | $ | 4,530 | $ | — | $ | 15,594 | $ | 8,163 | $ | 7,431 | $ | — | ||||||||||||||||
|
16
March 31, 2011 | December 31, 2010 | |||||||||||||||
Carrying | Carrying | |||||||||||||||
Fair Value | Value | Fair Value | Value | |||||||||||||
Notes payable — current
|
$ | 21,883 | $ | 21,883 | $ | 15,038 | $ | 15,038 | ||||||||
Long-term debt
|
631,005 | 615,010 | 565,499 | 550,368 | ||||||||||||
|
||||||||||||||||
Total debt instruments
|
$ | 652,888 | $ | 636,893 | $ | 580,537 | $ | 565,406 | ||||||||
|
17
2011 | 2010 | |||||||
DNA
|
||||||||
Customer revenues
|
$ | 305,964 | $ | 296,200 | ||||
Intersegment revenues
|
19,626 | 19,145 | ||||||
Operating profit
|
17,406 | 9,284 | ||||||
Capital expenditures
|
5,779 | 6,753 | ||||||
Depreciation
|
6,759 | 6,516 | ||||||
Property, plant and equipment, at cost
|
462,840 | 445,548 | ||||||
Total assets
|
1,012,990 | 1,090,791 | ||||||
|
||||||||
DI
|
||||||||
Customer revenues
|
308,193 | 322,799 | ||||||
Intersegment revenues
|
15,266 | 9,752 | ||||||
Operating (loss) profit
|
(8,537 | ) | 31,301 | |||||
Capital expenditures
|
5,123 | 4,350 | ||||||
Depreciation
|
5,224 | 6,151 | ||||||
Property, plant and equipment, at cost
|
193,471 | 165,319 | ||||||
Total assets
|
1,518,547 | 1,428,770 | ||||||
|
||||||||
TOTAL
|
||||||||
Customer revenues
|
614,157 | 618,999 | ||||||
Intersegment revenues
|
34,892 | 28,897 | ||||||
Operating profit
|
8,869 | 40,585 | ||||||
Capital expenditures
|
10,902 | 11,103 | ||||||
Depreciation
|
11,983 | 12,667 | ||||||
Property, plant and equipment, at cost
|
656,311 | 610,867 | ||||||
Total assets
|
2,531,537 | 2,519,561 |
2011 | 2010 | |||||||
Diebold North America
|
$ | 305,964 | $ | 296,200 | ||||
Diebold International:
|
||||||||
Latin America including Brazil
|
152,888 | 149,527 | ||||||
Asia Pacific
|
83,889 | 98,442 | ||||||
Europe, Middle East and Africa
|
71,416 | 74,830 | ||||||
|
||||||||
Total Diebold International
|
308,193 | 322,799 | ||||||
|
||||||||
Total customer revenues
|
$ | 614,157 | $ | 618,999 | ||||
|
18
2011 | 2010 | |||||||
Financial self-service:
|
||||||||
Products
|
$ | 198,640 | $ | 203,700 | ||||
Services
|
264,456 | 267,808 | ||||||
|
||||||||
Total financial self-service
|
463,096 | 471,508 | ||||||
Security:
|
||||||||
Products
|
43,413 | 51,450 | ||||||
Services
|
99,918 | 93,441 | ||||||
|
||||||||
Total security
|
143,331 | 144,891 | ||||||
|
||||||||
Total financial self-service & security
|
606,427 | 616,399 | ||||||
Election and lottery systems:
|
7,730 | 2,600 | ||||||
|
||||||||
Total customer revenues
|
$ | 614,157 | $ | 618,999 | ||||
|
19
20
• | demand for new service offerings, including integrated services and outsourcing; | ||
• | demand for security products and services for the financial, enterprise, retail and government sectors; | ||
• | timing of a self-service upgrade and/or replacement cycle, including deposit automation in mature markets such as the United States; and | ||
• | high levels of deployment growth for new self-service products in emerging markets, such as Asia Pacific. |
21
Three Months Ended | ||||||||||||||||
March 31, | ||||||||||||||||
2011 | 2010 | |||||||||||||||
% of | % of | |||||||||||||||
Dollars | Net sales | Dollars | Net sales | |||||||||||||
Net sales
|
$ | 614,157 | 100.0 | $ | 618,999 | 100.0 | ||||||||||
Gross profit
|
149,404 | 24.3 | 158,010 | 25.5 | ||||||||||||
Operating expenses
|
140,535 | 22.9 | 117,425 | 19.0 | ||||||||||||
Operating profit
|
8,869 | 1.4 | 40,585 | 6.6 | ||||||||||||
Income from continuing operations
|
4,146 | 0.7 | 25,192 | 4.1 | ||||||||||||
Loss from discontinued operations, net of tax
|
(11 | ) | (970 | ) | ||||||||||||
Net income attributable to noncontrolling interests
|
1,634 | 298 | ||||||||||||||
Net income attributable to Diebold, Incorporated
|
2,501 | 23,924 |
2011 | 2010 | $ Change | % Change | |||||||||||||
Net sales
|
$ | 614,157 | $ | 618,999 | $ | (4,842 | ) | (0.8 | ) |
22
$ Change/ | ||||||||||||||||
2011 | 2010 | % Point Change | % Change | |||||||||||||
Gross profit — products
|
$ | 60,920 | $ | 65,468 | $ | (4,548 | ) | (6.9 | ) | |||||||
Gross profit — services
|
88,484 | 92,542 | (4,058 | ) | (4.4 | ) | ||||||||||
|
||||||||||||||||
Total gross profit
|
$ | 149,404 | $ | 158,010 | $ | (8,606 | ) | (5.4 | ) | |||||||
|
||||||||||||||||
|
||||||||||||||||
Gross margin — products
|
24.4 | % | 25.4 | % | (1.0 | ) | ||||||||||
Gross margin — services
|
24.3 | % | 25.6 | % | (1.3 | ) | ||||||||||
|
||||||||||||||||
Total gross margin
|
24.3 | % | 25.5 | % | (1.2 | ) | ||||||||||
|
2011 | 2010 | $ Change | % Change | |||||||||||||
Selling and administrative expense
|
$ | 121,111 | $ | 98,977 | $ | 22,134 | 22.4 | |||||||||
Research, development and engineering expense
|
19,424 | 18,448 | 976 | 5.3 | ||||||||||||
|
||||||||||||||||
Total operating expenses
|
$ | 140,535 | $ | 117,425 | $ | 23,110 | 19.7 | |||||||||
|
23
$ Change/ | ||||||||||||||||
2011 | 2010 | % Point Change | % Change | |||||||||||||
Operating profit
|
$ | 8,869 | $ | 40,585 | $ | (31,716 | ) | (78.1 | ) | |||||||
Operating profit margin
|
1.4 | % | 6.6 | % | (5.2 | ) |
2011 | 2010 | $ Change | % Change | |||||||||||||
Investment income
|
$ | 10,898 | $ | 7,471 | $ | 3,427 | 45.9 | |||||||||
Interest expense
|
(8,673 | ) | (9,055 | ) | 382 | (4.2 | ) | |||||||||
Foreign exchange loss, net
|
(1,046 | ) | (4,641 | ) | 3,595 | (77.5 | ) | |||||||||
Miscellaneous, net
|
23 | 709 | (686 | ) | (96.8 | ) | ||||||||||
|
||||||||||||||||
Other income (expense)
|
$ | 1,202 | $ | (5,516 | ) | $ | 6,718 | N/M | ||||||||
|
$ Change/ | ||||||||||||||||
2011 | 2010 | % Point Change | % Change | |||||||||||||
Income from continuing operations
|
$ | 4,146 | $ | 25,192 | $ | (21,046 | ) | (83.5 | ) | |||||||
Percent of net sales
|
0.7 | % | 4.1 | % | (3.4 | ) | ||||||||||
Effective tax rate
|
58.8 | % | 28.2 | % | 30.6 |
2011 | 2010 | $ Change | % Change | |||||||||||||
Loss from discontinued operations, net of tax
|
$ | (11 | ) | $ | (970 | ) | $ | 959 | (98.9 | ) |
24
2011 | 2010 | $ Change | % Change | |||||||||||||
Net income attributable to Diebold, Incorporated
|
$ | 2,501 | $ | 23,924 | $ | (21,423 | ) | (89.5 | ) |
2011 | 2010 | $ Change | % Change | |||||||||||||
DNA
|
$ | 305,964 | $ | 296,200 | $ | 9,764 | 3.3 | |||||||||
DI
|
308,193 | 322,799 | (14,606 | ) | (4.5 | ) | ||||||||||
|
||||||||||||||||
Total net sales
|
$ | 614,157 | $ | 618,999 | $ | (4,842 | ) | (0.8 | ) | |||||||
|
2011 | 2010 | $ Change | % Change | |||||||||||||
DNA
|
$ | 17,406 | $ | 9,284 | $ | 8,122 | 87.5 | |||||||||
DI
|
(8,537 | ) | 31,301 | (39,838 | ) | (127.3 | ) | |||||||||
|
||||||||||||||||
Total operating profit
|
$ | 8,869 | $ | 40,585 | $ | (31,716 | ) | (78.1 | ) | |||||||
|
25
2011 | 2010 | |||||||
Net cash flow (used in) provided by:
|
||||||||
Operating activities
|
$ | (90,151 | ) | $ | (56,223 | ) | ||
Investing activities
|
2,197 | (2,732 | ) | |||||
Financing activities
|
35,958 | 5,504 | ||||||
Effect of exchange rate changes on cash and
cash equivalents
|
2,900 | (9,102 | ) | |||||
|
||||||||
Net decrease in cash and cash equivalents
|
$ | (49,096 | ) | $ | (62,553 | ) | ||
|
26
Total | 2011 | 2012 | ||||||||||
Direct purchasing agreement
|
$ | 4,992 | $ | 4,515 | $ | 477 |
27
• | competitive pressures, including pricing pressures and technological developments; |
• | changes in the Company’s relationships with customers, suppliers, distributors and/or partners in its business ventures; |
• | changes in political, economic or other factors such as currency exchange rates, inflation rates, recessionary or expansive trends, taxes and regulations and laws affecting the worldwide business in each of the Company’s operations, including Brazil, where a significant portion of the Company’s revenue is derived; |
• | the amount of cash and non-cash charges in connection with the restructuring of the Company’s EMEA operations; |
• | the Company’s ability to take actions to mitigate the effect of the Venezuelan currency devaluation, further devaluation, actions of the Venezuelan government, and economic conditions in Venezuela; |
• | the continuing effects of the economic downturn and the disruptions in the financial markets, including the bankruptcies, restructurings or consolidations of financial institutions, which could reduce our customer base and/or adversely affect our customers’ ability to make capital expenditures, as well as adversely impact the availability and cost of credit; |
• | acceptance of the Company’s product and technology introductions in the marketplace; |
• | the Company’s ability to maintain effective internal controls; |
• | changes in the Company’s intention to repatriate cash and cash equivalents and short-term investments residing in international tax jurisdictions could negatively impact foreign and domestic taxes; |
• | unanticipated litigation, claims or assessments, as well as the impact of any current or pending lawsuits; |
• | variations in consumer demand for financial self-service technologies, products and services; |
• | potential security violations to the Company’s information technology systems; |
• | the investment performance of the Company’s pension plan assets, which could require us to increase the Company’s pension contributions, and significant changes in health care costs, including those that may result from government action such as the recently enacted U.S. health care legislation; |
• | the amount and timing of repurchases of the Company’s common shares, if any; |
• | the outcome of the Company’s global FCPA review and any actions taken by government agencies in connection with the Company’s self disclosure, including the pending SEC investigation; and | |
• | the Company’s ability to achieve benefits from its cost-reduction initiatives and other strategic changes. |
28
• | McDermott v. Diebold, Inc., et al. , No. 5:06CV170 (N.D. Ohio, filed January 24, 2006). | ||
• | Barnett v. Diebold, Inc., et al., No. 5:06CV361 (N.D. Ohio, filed February 15, 2006). | ||
• | Farrell v. Diebold, Inc., et al. , No. 5:06CV307 (N.D. Ohio, filed February 8, 2006). | ||
• | Forbes v. Diebold, Inc., et al. , No. 5:06CV324 (N.D. Ohio, filed February 10, 2006). | ||
• | Gromek v. Diebold, Inc., et al. , No. 5:06CV579 (N.D. Ohio, filed March 14, 2006). |
29
30
Maximum | ||||||||||||||||
Total Number of | Number of Shares | |||||||||||||||
Total Number | Shares Purchased as | that May Yet Be | ||||||||||||||
of Shares | Average Price | Part of Publicly | Purchased Under | |||||||||||||
Period | Purchased (1) | Paid Per Share | Announced Plans (2) | the Plans (2) | ||||||||||||
January
|
6,092 | $ | 32.44 | — | 2,123,051 | |||||||||||
February
|
220,828 | 34.17 | 132,000 | 3,868,000 | ||||||||||||
March
|
391,000 | 35.06 | 391,000 | 3,477,000 | ||||||||||||
|
||||||||||||||||
Total
|
617,920 | 34.71 | 523,000 | |||||||||||||
|
(1) | Includes 6,092 and 88,828 shares in January and February, respectively, surrendered or deemed surrendered to the Company in connection with the Company’s share-based compensation plans. | |
(2) | The Company purchased 523,000 common shares in the first quarter of 2011 pursuant to its share repurchase plan. The total number of shares repurchased as part of the publicly announced share repurchase plan was 10,399,949 as of March 31, 2011. The plan was approved by the Board of Directors in April 1997 and authorized the repurchase of up to 2.0 million shares. The plan was amended in June 2004 to authorize the repurchase of an additional 2.0 million shares, and was further amended in August and December 2005 to authorize the repurchase of an additional six million shares. In February 2007, the Board of Directors approved an increase in the Company’s share repurchase program by authorizing the repurchase of up to an additional 2.0 million of the Company’s outstanding common shares. In February 2011, the Board of Directors approved an increase in the Company’s share repurchase program by authorizing the repurchase of up to an additional 1.9 million of the Company’s outstanding common shares. The Company may purchase shares from time to time in open market purchases or privately negotiated transactions. The Company may make all or part of the purchases pursuant to accelerated share repurchases or Rule 10b5-1 plans. The plan has no expiration date. |
31
3.1(i)
|
Amended and Restated Articles of Incorporation of Diebold, Incorporated — incorporated by reference to Exhibit 3.1(i) to Registrant’s Annual Report on Form 10-K for the year ended December 31, 1994 (Commission File No. 1-4879) | |
|
||
3.1(ii)
|
Amended and Restated Code of Regulations — incorporated by reference to Exhibit 3.1(ii) to Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2007 (Commission File No. 1-4879) | |
|
||
3.2
|
Certificate of Amendment by Shareholders to Amended Articles of Incorporation of Diebold, Incorporated — incorporated by reference to Exhibit 3.2 to Registrant’s Form 10-Q for the quarter ended March 31, 1996 (Commission File No. 1-4879) | |
|
||
3.3
|
Certificate of Amendment to Amended Articles of Incorporation of Diebold, Incorporated — incorporated by reference to Exhibit 3.3 to Registrant’s Form 10-K for the year ended December 31, 1998 (Commission File No. 1-4879) | |
|
||
31.1
|
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
|
||
31.2
|
Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
|
||
32.1
|
Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350 | |
|
||
32.2
|
Certification of Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350 | |
|
||
*101.INS
|
XBRL Instance Document | |
|
||
*101.SCH
|
XBRL Taxonomy Extension Schema Document | |
|
||
*101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document | |
|
||
*101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document | |
|
||
*101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document |
* | XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections. |
32
DIEBOLD, INCORPORATED | ||||
(Registrant)
|
||||
Date: May 4, 2011 | By: | /s/ Thomas W. Swidarski | ||
Thomas W. Swidarski | ||||
President and Chief Executive Officer
(Principal Executive Officer) |
||||
Date: May 4, 2011 | By: | /s/ Bradley C. Richardson | ||
Bradley C. Richardson | ||||
Executive Vice President and Chief Financial Officer
(Principal Financial Officer) |
||||
33
EXHIBIT NO. | DOCUMENT DESCRIPTION | |
|
||
31.1
|
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
|
||
31.2
|
Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
|
||
32.1
|
Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350. | |
|
||
32.2
|
Certification of Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350. | |
|
||
*101.INS
|
XBRL Instance Document | |
|
||
*101.SCH
|
XBRL Taxonomy Extension Schema Document | |
|
||
*101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document | |
|
||
*101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document | |
|
||
*101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document |
* | XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections. |
34
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
No Customers Found
Suppliers
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|